Pradžia › Priepuoliai › Ilinoisas
Priepuoliai klinikiniai tyrimai Ilinoisas
8 tyrimai dėl Priepuoliai ieško dalyvių vietose Ilinoisas.
Miestai Ilinoisas
Oficialus tyrimo tekstas (anglų kalba)
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- Re:Cognition Health, Chicago
Renkami dalyviai3 fazė
Amžius nuo 2 iki 55 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05066217A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- Northwestern University, Chicago
Renkami dalyviai1 fazė
Amžius nuo 12 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07233239RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Southern Illinois University School of Medicine, Springfield
Renkami dalyviai2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-10-01 · NCT06798896Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Re:Cognition Health-Chicago, Chicago
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-02 · NCT07594119Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Renkami dalyviaiStebimasis tyrimas
Iki 26 metų · Visoms lytims · Atnaujinta 2026-08-06 · NCT05374824A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
- Praxis Research Site, Chicago
Renkami dalyviai3 fazė
1 Day – 18 Years · Visoms lytims · Atnaujinta 2026-08-03 · NCT07019922Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Rush University Medical Center, Chicago
- University of Chicago, Chicago
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-06-09 · NCT05135091A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Southern Illinois University School of Medicine, Springfield
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-14 · NCT05716100Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.